Eosin Pharma Trenta 2% Cutaneous Solution 50 g

Therapeutic indications

Local treatment for the disinfection of small wounds, abrasions, burns, insect bites, diaper rashes, bedsores and sores in general.

Dosage

Apply a few drops 1 - 2 times a day, using a clean gauze or pour directly on the area to be treated; cover with an appropriate dry sterile bandage if necessary.

Overdose

There are no known toxic phenomena due to overdose.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Side effects

The undesirable effects of eosin are listed below, organized according to the MedDRA system organ class. Insufficient data are available to establish the frequency of the individual effects listed. Immune system disorders - Hypersensitivity reactions Skin and subcutaneous tissue disorders - Contact dermatitis

Pregnancy and breastfeeding

Since systemic absorption is negligible, no adverse effects on the fetus during pregnancy and on the baby during lactation are foreseeable.

Special warnings

Avoid application near the eyes. Eosin cutaneous solution colors the skin red; the spots disappear in about three days. Important information about some of the ingredients: None in particular

Expiry and Retention

Store in a tightly closed container, away from light.

Active principles

EOSINA PHARMA TRENTA - 1% cutaneous solution 100 g of 1% solution contain Active ingredient : eosin 1 g. EOSINA PHARMA TRENTA 2% cutaneous solution 100 g of 2% solution contain Active ingredient : eosin 2 g. For a complete list of excipients, see par. 6.1.

Excipients

2 – Bromine – 2 – Nitropropane – 1,3 – Diol, imidazolidinylurea, purified water.